Delivery Order SPE2DE21D0007-SPE2D624F0S68
Award Date 3/14/24
Potential Completion Date 4/3/24
Potential Value $1.5K
Federal Agency
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Raritan, NJ 08869, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer and self-certified HUBZone joint venture, by the Medical Supply Chain division of the Defense agency. The $5,299.18 fixed-price delivery order contract is for the supply of 4,568,054,958 units of "ANTI-DST 15X10ML" medical products, with a completion date of May 12, 2025. The contract was awarded on April 28, 2025 and does not utilize any set-aside designations,...
- This is a federal contract award from the Medical Supply Chain (an alternate name for the Defense Agency), valued at $1,305.93, awarded to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer. The contract is a Delivery Order, with a fixed price and economic price adjustment pricing type, and an ultimate completion date of June 20, 2025. It does not have a set-aside designation. Ortho-Clinical Diagnostics, Inc. is a self-certified HUBZone joint venture that specializes...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Ortho-Clinical Diagnostics, Inc., a medical equipment manufacturer. The $1,037.23 firm fixed price delivery order is for the supply of 4566514555 REAGENT ANTI-D BIOCLONE 150ML MONOCLONAL. The ultimate completion date for this contract is November 26, 2024. Ortho-Clinical Diagnostics has provided a range of medical equipment, reagents, and testing services to federal agencies...
- This federal contract award is for the delivery of "REAGENT ANTI-D BIOCLONE 150ML MONOCLONAL" to the Medical Supply Chain, a component of the Defense Logistics Agency (DLA). The contract was awarded to Ortho-Clinical Diagnostics, Inc., a medical equipment manufacturing company, on November 20, 2024 with a ceiling value of $1,037.23. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of November 25, 2024. The contract does not...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order contract worth $1,037.23 to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, for the supply of 150 ml vials of Reagent Anti-D Bioclone. The contract has a completion date of February 21, 2024. Ortho-Clinical Diagnostics, Inc. is a self-certified HUBZone joint venture that has provided a range of diagnostic solutions, including COVID-19 tests and immunodiagnostic equipment,...
- This federal contract award to Ortho-Clinical Diagnostics, Inc., a self-certified HUBZone joint venture manufacturer, was issued by the Medical Supply Chain division of the Defense Logistics Agency. The $2,869.77 firm-fixed-price delivery order is for the supply of 150 ml bottles of Reagent Anti-D Bioclone, a critical medical reagent. The contract has an ultimate completion date of October 3, 2024. Ortho-Clinical Diagnostics has previously provided a range of medical equipment, reagents, and...
- This is a federal contract award to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, by the Medical Supply Chain division of the Defense agency. The contract is for the delivery of Blood Group Serum 15S, with a ceiling value of $2,904.77 and a period of performance ending on May 7, 2025. The contract is a Delivery Order with a Fixed Price with Economic Price Adjustment pricing type. It does not have a set-aside designation, indicating open competition....
- This is a federal contract award from the Defense Health Agency (DHA) to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer. The $5,739.54 firm fixed-price delivery order is for the supply of 4567948697 REAGENT ANTI-D BIOCLONE 150ML MONOCLONAL. The contract has an ultimate completion date of April 21, 2025 and was awarded on April 16, 2025. Ortho-Clinical Diagnostics, Inc. is a self-certified HUBZone joint venture and the contract does not utilize any set-aside...
- This is a $1,037.23 firm fixed-price delivery order contract awarded by the Defense Health Agency to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, for the supply of 150 ml monoclonal anti-D reagent. The contract has an ultimate completion date of November 25, 2024 and does not utilize any set-aside designations. Ortho-Clinical Diagnostics is a provider of medical diagnostic solutions, including COVID-19 tests and immunodiagnostic/clinical chemistry analyzers, and...
- This is a firm fixed price delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency Troop Support to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer. The $1,037.23 contract provides 150 milliliter bottles of Reagent Anti-D Bioclone, a critical diagnostic reagent. Ortho-Clinical Diagnostics has provided a range of medical equipment, reagents, and services to various federal healthcare agencies, including the Department of...